Sanofi Said to Be in Advanced Talks to Acquire Actelion
Sanofi is in advanced talks to acquire Actelion Ltd., according to people with knowledge of the matter, in a deal for the Swiss drugmaker that could be announced as soon as next week. The companies are discussing a price of about $275 per Actelion share, the people said, asking not to be identified because the negotiations are private.
from Biotech News
0 Comments